Dr. Mark Correa, MD

Dr. Correa practices at Southwest Skin and Vein Center in Buda, Texas.

Dr. Correa's NPI, 1962864488, was assigned on March 23, 2016. Dr. Correa graduated from University Of Florida College Of Medicine in 2016. Dr. Correa holds Texas license S5147.

Dr. Correa's primary practice is Southwest Skin and Vein Center, at 211 N Fm-1626, Buda, TX 78610 in Hays County. The practice phone is (512) 444-7208.

Dr. Correa's primary practice is Southwest Skin and Vein Center in Buda, Texas. The medical group on file is Southwest Dermatology & Vein. Dmand AI also links Dr. Correa to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Correa practices. Vendor and product names are available with a free account.

Dermatology is Dr. Correa's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Correa is board certified in dermatology by the American Board of Dermatology. Dr. Correa is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Correa treats.

CMS data shows 3,987 Medicare services from Dr. Correa across 14 procedure codes in 2024, for 672 Medicare patients. Medicare paid $169,773 for them. Every service was in an office.

CMS counts 672 Medicare patients who saw Dr. Correa in 2024. The largest group is 65 to 74, with 302 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Correa's median patient age at 66, with 37% women.

In 2024, Dr. Correa wrote 1,388 Medicare Part D claims for 501 patients. 91% of them were for generic drugs. CMS names the drug for 1,278 of them, across 25 drugs with 11 or more claims each, at $348,757 in total drug cost. In 2023, CMS named 1,120 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Correa for performance year 2024, reported as part of a group. Dr. Correa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,102 procedures of removal of skin lesions by Dr. Correa, more than 94% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Correa, published from 2014 to 2021. Dr. Correa's most frequent co-authors are Paula Jean Beers, MD, Kenneth Cusi, MD and Cory A. Dunnick, MD.

CMS Open Payments shows 217 general payments to Dr. Correa from 22 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $880.

Dr. Correa graduated from University Of Florida College Of Medicine in 2016.

Dr. Correa is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.